Search Result "evolocumab."


Review Article

Effects of Evolocumab on Cardiovascular Events

Journal: Current Cardiology Reviews
Volume: 13 Issue: 4 Year: 2017 Page: 319-324
Author(s): Nasser Mikhail

Review Article

Three Musketeers for Lowering Cholesterol: Statins, Ezetimibe and Evolocumab

Journal: Current Medicinal Chemistry
Volume: 28 Issue: 5 Year: 2021 Page: 1025-1041
Author(s): Qian Xu,Yiming Deng,Jun Xiao,Xiangrui Liu,Min Zhou,Zhong Ren,Juan Peng,Yaling Tang,Zhisheng Jiang,Zhihan Tang,Lushan Liu

Research Article

Efficacy and Safety of Evolocumab in Reducing Low-Density Lipoprotein Cholesterol Levels in Chinese Patients with Non-ST-segment Elevation Acute Coronary Syndrome

Journal: Current Vascular Pharmacology
Volume: 19 Issue: 4 Year: 2021 Page: 429-437
Author(s): Xiaohan Xu,Meng Chai,Yujing Cheng,Pingan Peng,Xiaoli Liu,Zhenxian Yan,Yonghe Guo,Yingxin Zhao,Yujie Zhou

PCSK9 Inhibition with Evolocumab Reaching Physiologic LDL-C Levels for Reducing Atherosclerotic Burden and Cardiovascular Disease-The Full Landscape

Ebook: Recent Advances in Alzheimer Research
Volume: 4 Year: 2019
Author(s): Enrique C. Morales-Villegas,Kausik K. Ray
Doi: 10.2174/97816810839951180401

Systematic Review Article

Efficacy and Safety of Alirocumab and Evolocumab as ProproteinConvertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors in FamilialHypercholesterolemia: A Systematic Review and Meta-Analysis

Journal: Current Medicinal Chemistry
Volume: 31 Issue: 2 Year: 2024 Page: 223-241
Author(s): Ali Akbar Soleimani

Review Article

Anti-PCSK9 Antibodies: A New Era in the Treatment of Dyslipidemia

Journal: Current Pharmaceutical Design
Volume: 23 Issue: 10 Year: 2017 Page: 1484-1494
Author(s): Joel Schmitz,Ioanna Gouni-Berthold

Cross-Sectional Study

Analysis of Adherence to anti-PCSK9 Antibody Therapy among Patients from Italy

Journal: Cardiovascular & Hematological Disorders-Drug Targets
Volume: 23 Issue: 2 Year: 2023 Page: 111-121
Author(s):

Review Article

PCSK9 Inhibition in Atherosclerotic Cardiovascular Disease

Journal: Current Pharmaceutical Design
Volume: 29 Issue: 23 Year: 2023 Page: 1802-1824
Author(s):

Review Article

Role of PCSK9 Inhibitors in High Risk Patients with Dyslipidemia: Focus on Familial Hypercholesterolemia

Journal: Current Pharmaceutical Design
Volume: 24 Issue: 31 Year: 2018 Page: 3647-3653
Author(s): Vasilios Papademetriou,Konstantinos Stavropoulos,Christodoulos Papadopoulos,Konstantinos Koutsampasopoulos,Kiriakos Dimitriadis,Kostas Tsioufis

Familial Hypercholesterolemia: Etiology, Diagnosis and New Treatment Options

Journal: Current Pharmaceutical Design
Volume: 20 Issue: 4 Year: 2014 Page: 6220-6229
Author(s): Ioanna Gouni-Berthold, Heiner K. Berthold

Previous   Next

Go to   Results 1 - 1 of 82

Apply Filters

Volume Years
Article Type
Publication Title
Subject Title

Content Type


Ads